14 January 2025
Coulter Partners secures top finance Executive for ARTIDIS AG

Coulter Partners successfully completed a search assignment for ARTIDIS and is pleased to announce the placement of Dominique Leutwyler as Chief Financial Officer (CFO).
Dominique Leutwyler is a highly experienced finance leader with a strong track record in the Swiss MedTech industry. He played a key role in the successful growth of Medartis, a medical device company, from a startup to a global leader. His experience includes international expansion, acquisitions, and a successful IPO.
Commenting on the collaboration with Coulter Partners, Dr Marija Plodinec, Ph.D., Co-founder and CEO of ARTIDIS, said:
“Coulter Partners showcased a profound understanding of our industry and our company’s unique needs. Their expertise and extensive network enabled them to deliver exceptional candidates. We're very happy with the outcome as we welcome Dominique to our team.”
ARTIDIS AG is a Swiss health technology company on a mission to revolutionize cancer care by moving diagnostic and treatment response analyses from central laboratories to the patient's bedside. They have developed the first nanomechanical biomarker for cancer, enabling faster and more precise diagnoses and treatment predictions immediately after a biopsy is taken.
----

Dominique Leutwyler, Chief Financial Officer at ARTIDIS
Dominique brings over 25 years of leadership experience in financial strategy and organizational growth, with a remarkable track record in the Swiss MedTech industry. Most notably, Dominique served as CFO at Medartis, where he helped transform the company from a small startup into a global leader in trauma medical devices. Under his leadership, Medartis achieved significant milestones, including international expansion, strategic acquisitions, and a successful IPO on the SIX Swiss Exchange in 2018.
About ARTIDIS
For more information, please visit www.artidis.com
About Coulter Partners
www.coulterpartners.com
Related
-
Events
SACHS 18th Annual European Life Sciences CEO Forum
26 February 2025 – 27 February 2025
-
Press Releases
Coulter Partners secures Senior Vice President of Partnerships for Entia
26 November 2024
-
Press Releases
Coulter Partners strengthens leadership at IMU Biosciences with placements of Chief Executive Officer and Chief Business Officer
11 November 2024
-
Press Releases
Coulter Partners places new Chair at ArcticZymes Technologies
28 October 2024